tiprankstipranks
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (HK:1858)
:1858
Hong Kong Market
Want to see HK:1858 full AI Analyst Report?

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) Ratios

0 Followers

Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Ratios

HK:1858's free cash flow for Q1 2026 was ¥0.66. For the 2026 fiscal year, HK:1858's free cash flow was decreased by ¥ and operating cash flow was ¥0.29. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
6.09 5.20 5.20 4.44 4.66
Quick Ratio
4.98 4.28 4.19 3.80 4.23
Cash Ratio
2.65 2.44 2.08 1.87 1.61
Solvency Ratio
0.52 0.53 0.25 0.41 0.49
Operating Cash Flow Ratio
0.98 0.71 >-0.01 0.76 0.07
Short-Term Operating Cash Flow Coverage
239.60 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 2.39B¥ 2.42B¥ 2.20B¥ 2.24B¥ 2.09B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.19 1.23 1.23 1.27 1.25
Debt Service Coverage Ratio
146.40 1.35K 3.61K 856.65 7.23K
Interest Coverage Ratio
7.67K 1.50K 2.91K 838.61 7.04K
Debt to Market Cap
<0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
-3.96 -4.69 -6.73 -3.71 -2.60
Profitability Margins
Gross Profit Margin
65.43%63.29%64.09%72.48%76.03%
EBIT Margin
29.06%25.64%16.34%25.32%28.04%
EBITDA Margin
31.71%29.67%21.01%28.19%30.54%
Operating Profit Margin
29.11%29.91%16.22%25.32%27.37%
Pretax Profit Margin
29.56%29.86%16.33%25.31%28.04%
Net Profit Margin
26.75%26.97%15.51%22.99%25.61%
Continuous Operations Profit Margin
26.75%26.98%15.47%22.99%25.61%
Net Income Per EBT
90.49%90.33%94.98%90.82%91.34%
EBT Per EBIT
101.53%99.82%100.68%99.98%102.42%
Return on Assets (ROA)
7.59%7.44%3.61%7.61%9.02%
Return on Equity (ROE)
9.25%9.13%4.43%9.66%11.31%
Return on Capital Employed (ROCE)
9.55%9.80%4.48%10.29%11.69%
Return on Invested Capital (ROIC)
8.64%8.85%4.24%9.34%10.67%
Return on Tangible Assets
7.85%7.69%3.74%7.94%9.41%
Earnings Yield
4.28%5.33%4.11%6.69%5.69%
Efficiency Ratios
Receivables Turnover
3.49 4.36 2.03 2.74 1.57
Payables Turnover
2.27 2.31 1.27 1.48 1.21
Inventory Turnover
0.66 0.69 0.53 0.77 1.11
Fixed Asset Turnover
2.13 2.07 1.72 2.60 2.58
Asset Turnover
0.28 0.28 0.23 0.33 0.35
Working Capital Turnover Ratio
0.42 0.43 0.35 0.54 0.57
Cash Conversion Cycle
497.46 452.93 586.86 362.73 260.98
Days of Sales Outstanding
104.68 83.63 179.44 133.41 233.10
Days of Inventory Outstanding
553.70 527.56 694.81 476.76 329.16
Days of Payables Outstanding
160.93 158.26 287.39 247.44 301.28
Operating Cycle
658.38 611.19 874.25 610.17 562.26
Cash Flow Ratios
Operating Cash Flow Per Share
1.25 1.07 >-0.01 1.33 0.11
Free Cash Flow Per Share
1.09 0.92 -0.13 1.24 0.04
CapEx Per Share
0.16 0.15 0.13 0.09 0.06
Free Cash Flow to Operating Cash Flow
0.87 0.86 26.89 0.94 0.39
Dividend Paid and CapEx Coverage Ratio
1.99 2.66 >-0.01 3.34 0.55
Capital Expenditure Coverage Ratio
7.86 7.11 -0.04 15.39 1.65
Operating Cash Flow Coverage Ratio
213.39 108.44 -2.19 291.92 31.20
Operating Cash Flow to Sales Ratio
0.46 0.41 >-0.01 0.42 0.03
Free Cash Flow Yield
6.48%6.88%-1.68%11.52%0.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.37 18.77 24.31 14.95 17.57
Price-to-Sales (P/S) Ratio
6.25 5.06 3.77 3.44 4.50
Price-to-Book (P/B) Ratio
2.11 1.71 1.08 1.44 1.99
Price-to-Free Cash Flow (P/FCF) Ratio
15.44 14.53 -59.48 8.68 335.68
Price-to-Operating Cash Flow Ratio
13.47 12.49 -1.60K 8.12 131.82
Price-to-Earnings Growth (PEG) Ratio
0.21 0.16 -0.45 -1.50 -1.26
Price-to-Fair Value
2.11 1.71 1.08 1.44 1.99
Enterprise Value Multiple
15.75 12.37 11.22 8.48 12.13
Enterprise Value
5.15B 3.71B 1.90B 2.89B 4.45B
EV to EBITDA
15.75 12.37 11.22 8.48 12.13
EV to Sales
5.00 3.67 2.36 2.39 3.70
EV to Free Cash Flow
12.34 10.54 -37.18 6.04 276.32
EV to Operating Cash Flow
10.77 9.06 -999.69 5.65 108.51
Tangible Book Value Per Share
7.67 7.70 7.11 7.07 6.73
Shareholders’ Equity Per Share
7.97 7.79 7.45 7.46 7.09
Tax and Other Ratios
Effective Tax Rate
0.10 0.10 0.05 0.09 0.09
Revenue Per Share
2.70 2.64 2.13 3.13 3.13
Net Income Per Share
0.72 0.71 0.33 0.72 0.80
Tax Burden
0.90 0.90 0.95 0.91 0.91
Interest Burden
1.02 1.16 1.00 1.00 1.00
Research & Development to Revenue
0.14 0.00 0.17 0.13 0.14
SG&A to Revenue
0.35 0.14 0.35 <0.01 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.73 1.54 -0.02 1.84 0.13
Currency in CNY